Want to keep up-to-date?
We have changed our company brand from Gilbert Technologies to just ..... Gilbert! This change reflects an underlying change in our legal structure, where Gilbert Innovation, Gilbert Therapeutics and Gilbert […]
The Gilbert team looks forward to exhibiting at SMI London on June 25th. Join us at this 2nd Soft Mist Inhaler conference and learn to make, develop, use, file and […]
Gilbert is a proud sponsor of the 7th European Symposium on Electrohydrodynamic Atomization and Electrospinning 2024. This year ESEE2024 is taking place in Leeuwarden, The Netherlands from April 24-26. We […]
Gilbert is hiring a System Architect based at our office on the High Tech Campus Eindhoven. At Gilbert we are developing a next-generation soft mist inhaler with a revolutionary new […]
The Gerard & Anton Awards ceremony highlights 10 promising start-ups in the Brainport Eindhoven region each year. Gilbert has been selected a one of the 2023 winners. Click here for […]
Dutch MedTech Company Gilbert Raises €7 Million Series A to Redefine Treatment for Lung Patients. Eindhoven, The Netherlands, June 7 2023 – Gilbert, today announced the completion of its €7 […]
Engineering the inhaler of the future What is the most important success factor to bring a medical technology from lab bench to hospital? At the High Tech Campus Eindhoven Technology […]
Gilbert names Scott Fleming Chief Commercial Officer. Click here for the full press release.
Gilbert Announces George Hersbach to serve as Executive Chairman and Transition Role of CEO to Current COO Maurits Huigen. Click here for the full press release.
Interview with our COO Maurits Huigen after the nomination of Gilbert as one of the promising respiratory device solution providers by Medical Tech Outlook Magazine.
The startup company Gilbert R&D B.V., a subsidiary of Gilbert B.V., announces today that it has received funding for the development of a new generation soft mist inhalers for the […]
Belgium UCLouvain Louvain Drug Research Institute (LDRI) and Netherlands MedTech Start-up Gilbert join efforts for improved therapy for Cystic Fibrosis Patients.LDRI receives funding for the development of a long-acting PEGylated […]
MedTech Magazine, December 2018 When it comes to pulmonary drug administration and therapy adherence, it is noted that many of the commercially available inhalers such as Dry Powder Inhalers (DPIs) and […]
Let’s stay in touch!
Stay up-to-date with Gilbert’s latest news, vacancies and achievements by following us on social media.